Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 4429

1.

Comparison of the risk of psychological and cognitive disorders between persistent and nonpersistent statin users.

Lilly SM, Mortensen EM, Frei CR, Pugh MJ, Mansi IA.

Am J Cardiol. 2014 Oct 1;114(7):1035-9. doi: 10.1016/j.amjcard.2014.07.010. Epub 2014 Jul 16.

PMID:
25212545
[PubMed - in process]
2.

A Randomized Controlled Trial Comparing Cognitive Behavior Therapy, Cognitive Adaptation Training, Their Combination and Treatment as Usual in Chronic Schizophrenia.

Velligan DI, Tai S, Roberts DL, Maples-Aguilar N, Brown M, Mintz J, Turkington D.

Schizophr Bull. 2014 Sep 5. pii: sbu127. [Epub ahead of print]

PMID:
25193976
[PubMed - as supplied by publisher]
3.

Neurobiology of cognitive remediation therapy for schizophrenia: a systematic review.

Thorsen AL, Johansson K, Løberg EM.

Front Psychiatry. 2014 Aug 15;5:103. doi: 10.3389/fpsyt.2014.00103. eCollection 2014. Review.

PMID:
25177300
[PubMed]
Free PMC Article
4.

Off-label Use of Memantine as Adjunctive Treatment in Schizophrenia: A Retrospective Case Series Study.

John JP, Lukose A, Manjunath S.

Pharmacopsychiatry. 2014 Sep;47(6):202-9. doi: 10.1055/s-0034-1385931. Epub 2014 Aug 28.

PMID:
25167200
[PubMed - in process]
5.

Illusory Superiority and Schizotypal Personality: Explaining the Discrepancy Between Subjective/Objective Psychopathology.

Cohen AS, Auster TL, MacAulay RK, McGovern JE.

Personal Disord. 2014 Aug 25. [Epub ahead of print]

PMID:
25150366
[PubMed - as supplied by publisher]
6.

Understanding the Role α7 Nicotinic Receptors Play in Dopamine Efflux in Nucleus Accumbens.

Maex R, Grinevich VP, Grinevich V, Budygin E, Bencherif M, Gutkin B.

ACS Chem Neurosci. 2014 Aug 29. [Epub ahead of print]

PMID:
25147933
[PubMed - as supplied by publisher]
7.

Psychiatric signs and symptoms in treatable inborn errors of metabolism.

Nia S.

J Neurol. 2014 Sep;261 Suppl 2:559-68. doi: 10.1007/s00415-014-7396-6.

PMID:
25145892
[PubMed - in process]
Free PMC Article
8.

[Neurobiology of schizophrenia : New findings from the structure to the molecules.]

Schmitt A, Malchow B, Keeser D, Falkai P, Hasan A.

Nervenarzt. 2014 Aug 17. [Epub ahead of print] German.

PMID:
25123366
[PubMed - as supplied by publisher]
9.

Reboxetine adjuvant therapy in patients with schizophrenia showing a suboptimal response to clozapine: a 12-week, open-label, pilot study.

Bruno A, Zoccali R, Bellinghieri PM, Pandolfo G, De Fazio P, Spina E, Muscatello MR.

J Clin Psychopharmacol. 2014 Oct;34(5):620-3. doi: 10.1097/JCP.0000000000000196.

PMID:
25118083
[PubMed - in process]
10.

Relation between jumping to conclusions and cognitive functioning in people with schizophrenia in contrast with healthy participants.

Ochoa S, Haro JM, Huerta-Ramos E, Cuevas-Esteban J, Stephan-Otto C, Usall J, Nieto L, Brebion G.

Schizophr Res. 2014 Aug 8. pii: S0920-9964(14)00383-1. doi: 10.1016/j.schres.2014.07.026. [Epub ahead of print]

PMID:
25112159
[PubMed - as supplied by publisher]
11.

Cognitive remediation therapy (CRT) benefits more to patients with schizophrenia with low initial memory performances.

Pillet B, Morvan Y, Todd A, Franck N, Duboc C, Grosz A, Launay C, Demily C, Gaillard R, Krebs MO, Amado I.

Disabil Rehabil. 2014 Aug 11:1-8. [Epub ahead of print]

PMID:
25109501
[PubMed - as supplied by publisher]
12.

ASP5736, a novel 5-HT<sub>5A</sub> receptor antagonist, ameliorates positive symptoms and cognitive impairment in animal models of schizophrenia.

Yamazaki M, Harada K, Yamamoto N, Yarimizu J, Okabe M, Shimada T, Ni K, Matsuoka N.

Eur Neuropsychopharmacol. 2014 Jul 27. pii: S0924-977X(14)00206-5. doi: 10.1016/j.euroneuro.2014.07.009. [Epub ahead of print]

PMID:
25108314
[PubMed - as supplied by publisher]
Free Article
13.

Structural equation model of factors related to quality of life for community-dwelling schizophrenic patients in Japan.

Nakamura H, Watanabe N, Matsushima E.

Int J Ment Health Syst. 2014 Jul 25;8:32. doi: 10.1186/1752-4458-8-32. eCollection 2014.

PMID:
25101143
[PubMed]
Free PMC Article
14.

Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia.

Bishop JR, Reilly JL, Harris MS, Patel SR, Kittles R, Badner JA, Prasad KM, Nimgaonkar VL, Keshavan MS, Sweeney JA.

Psychopharmacology (Berl). 2014 Aug 7. [Epub ahead of print]

PMID:
25096017
[PubMed - as supplied by publisher]
15.

A pilot study: comparative research of social functioning, circadian rhythm parameters, and cognitive function among institutional inpatients, and outpatients with chronic schizophrenia and healthy elderly people.

Kume Y, Sugita T, Oga K, Kagami K, Igarashi H.

Int Psychogeriatr. 2014 Aug 5:1-9. [Epub ahead of print]

PMID:
25092490
[PubMed - as supplied by publisher]
16.

Cognitive therapy for patients with schizophrenia.

Bera SC, Sarkar S.

Lancet. 2014 Aug 2;384(9941):401. doi: 10.1016/S0140-6736(14)61274-5. No abstract available.

PMID:
25088856
[PubMed - indexed for MEDLINE]
17.

Cognitive therapy for patients with schizophrenia - Authors' reply.

Morrison AP, Dunn G, Turkington D, Pyle M, Hutton P.

Lancet. 2014 Aug 2;384(9941):401-2. doi: 10.1016/S0140-6736(14)61275-7. No abstract available.

PMID:
25088855
[PubMed - indexed for MEDLINE]
18.

Cognitive therapy for patients with schizophrenia.

Coyne JC, van Linschoten HS.

Lancet. 2014 Aug 2;384(9941):400. doi: 10.1016/S0140-6736(14)61273-3. No abstract available.

PMID:
25088854
[PubMed - indexed for MEDLINE]
19.

Cognitive therapy for patients with schizophrenia.

Kontis D, Theochari E, Tsaltas E.

Lancet. 2014 Aug 2;384(9941):400. doi: 10.1016/S0140-6736(14)61272-1. No abstract available.

PMID:
25088853
[PubMed - indexed for MEDLINE]
20.

Cognitive therapy for patients with schizophrenia.

Laws K, McKenna P.

Lancet. 2014 Aug 2;384(9941):399. doi: 10.1016/S0140-6736(14)61271-X. No abstract available.

PMID:
25088852
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk